Company News: Page (1) of 1 - 02/17/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

NHI Announces Fourth Quarter 2016 Results

(February 17, 2017)

MURFREESBORO, Tenn.--(BUSINESS WIRE)--National Health Investors, Inc. (NYSE:NHI) announced today its net income attributable to common stockholders, its Funds From Operations ("FFO"), its Normalized Funds From Operations and its Normalized Adjusted Funds From Operations (?AFFO) for the three and twelve months ended December 31, 2016.


2016 Highlights

  • Announced $447.7 million in acquisitions and loans
  • Issued $104.2 million of common equity on the Company's ATM
  • Normalized AFFO up 11.7% over fourth quarter 2015; up 7.1% for 2016
  • Maintained low leverage balance sheet at 4.4x net debt-to-annualized adjusted EBITDA
  • Portfolio lease coverage remains strong at 1.83x
  • Converted RIDEA joint venture with Bickford Senior Living to triple-net tenancy

Financial Results

  • Net income attributable to common stockholders per diluted common share for the three months ended December 31, 2016, was $1.03, a decrease of 28.4% from the same period in the prior year. Net income attributable to common stockholders per diluted common share for the year ended December 31, 2016, was $3.87, a decrease of 2.0% from the prior year.
  • Normalized FFO per diluted common share for the three months ended December 31, 2016, was $1.27, an increase of 8.5% over the same period in the prior year. Normalized FFO per diluted common share for the year ended December 31, 2016, was $4.87, an increase of 4.3% over the prior year.
  • Normalized AFFO per diluted common share for the three months ended December 31, 2016 was $1.15, an increase of 11.7% over the same period in the prior year. Normalized AFFO per diluted common share for the year ended December 31, 2016 was $4.39, an increase of 7.1% over the prior year.
  • FFO per diluted common share for the three months ended December 31, 2016, was $1.43, a decrease of 20.6% from the same period in the prior year. FFO per diluted common share for the year ended December 31, 2016, was $5.25, a decrease of 1.1% from the prior year.
  • FFO and net income attributable to common stockholders for the three months ended December 31, 2016 include gains on sales of marketable securities of $6.2 million compared to gains on sales of marketable securities of $23.5 million for the same period in the prior year. FFO and net income attributable to common stockholders for the year ended December 31, 2016 include $29.7 million of gains on sales of marketable securities and $14.7 million in non-cash write-offs of a lease intangible and straight-line rent receivable related to the transition of a lease on a portfolio of 15 skilled nursing facilities to The Ensign Group.

The Company defines Normalized FFO as FFO adjusted for certain items which may create some difficulty in comparing FFO for the current period to similar prior periods. We define Normalized AFFO as Normalized FFO excluding the effects of straight-line lease revenue, amortization of debt issuance costs and the non-cash amortization of the original issue discount of our unsecured convertible notes. These supplemental non-GAAP performance measures may not be comparable to similarly titled measures used by other REITs.


Net income attributable to common stockholders is a calculation of our net income, defined as the results of our operations in conformity with generally accepted accounting principles (GAAP) in the United States of America, less net income attributable to noncontrolling interests in our consolidated joint ventures, if any.

The reconciliation of net income attributable to common stockholders to our FFO, Normalized FFO, Normalized AFFO and Normalized FAD is included as a table to this press release and filed in the Company's Form 10-Q with the Securities and Exchange Commission.

2017 Guidance

The Company currently expects Normalized FFO for 2016 to be in the range of $5.06 to $5.12 per diluted common share and Normalized AFFO to be in the range of $4.61 to $4.65 per diluted common share. The Company's guidance range for the full year 2016, with underlying assumptions and timing of certain transactions, is set forth and reconciled below:

Full-Year 2017 Range
Low   High
Net income per diluted share attributable to common stockholders $ 3.47   $ 3.50
Plus: Depreciation 1.59   1.62  
Normalized FFO per diluted common share $ 5.06 $ 5.12
Less: Straight-line rental income (0.54 ) (0.56 )
Plus: Amortization of debt issuance costs 0.06 0.06
Plus: Amortization of original issue discount 0.03   0.03  
Normalized AFFO per diluted common share $ 4.61   $ 4.65  

The Companys guidance range reflects the existence of volatile economic conditions, but does not assume any material deterioration in tenant credit quality and/or performance of its portfolio. The Company does not include an estimate of investment volume in its guidance range, however, it includes future investments with existing and new tenants for which management estimates are reasonably likely at the present date. The guidance is based on a number of assumptions, many of which are outside the Companys control and all of which are subject to change. The Companys guidance range allows for the uncertainty inherent in the structure and timing of the financing required to fund previously announced investments and any pending new investments. The Companys guidance may change if actual results vary from these assumptions.

Investor Conference Call and Webcast

NHI will host a conference call on Friday, February 17, 2017, at 12 p.m. ET, to discuss fourth quarter results. The number to call for this interactive teleconference is (800) 699-3715 with the confirmation number, 21843254. The live broadcast of NHI's fourth quarter conference call will be available online at www.nhireit.com. The online replay will follow shortly after the call and continue for approximately 90 days.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHIs portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. Visit www.nhireit.com for more information.

 
Reconciliation of FFO, Normalized FFO, Normalized AFFO and Normalized FAD
(in thousands, except share and per share amounts)        
Three Months Ended Year Ended
December 31, December 31,
2016 2015 2016 2015
Net income attributable to common stockholders $ 41,188 $ 54,397 $ 151,540 $ 148,862
Elimination of certain non-cash items in net income:
Depreciation 15,897 13,660 59,565 53,163
Depreciation related to noncontrolling interest ? (301 ) (927 ) (1,150 )
Net gain on sales of real estate ?   ?   (4,582 ) (1,126 )
Funds from operations 57,085 67,756 205,596 199,749
Gain on sale of marketable securities (6,175 ) (23,468 ) (29,673 ) (23,529 )
Gain on sale of equity-method investee ? ? (1,657 ) ?
Write-off of deferred tax asset ? ? 1,192 ?
Non-cash write-off of straight-line rent receivable ? ? 9,456 ?
Write-off of lease intangible ? ? 6,400 ?
Revenue recognized due to early lease termination ? ? (303 ) ?
Recognition of unamortized mortgage note discount (288 ) ? (288 ) ?
Recovery of previous write-down ? ? ? (491 )
Normalized FFO 50,622 44,288 190,723 175,729
Straight-line lease revenue, net (5,615 ) (6,131 ) (22,198 ) (24,623 )
Straight-line lease revenue, net, related to noncontrolling interest ? 5 (4 ) 40
Amortization of original issue discount 291 279 1,145 1,101
Amortization of debt issuance costs 611 589 2,368 2,311
Amortization of debt issuance costs related to noncontrolling interest ?   (9 ) (27 ) (30 )
Normalized AFFO 45,909 39,021 172,007 154,528
Non-cash stock based compensation 251   204   1,732   2,134  
Normalized FAD $ 46,160  

 

$ 39,225   $ 173,739   $ 156,662  
 

BASIC

Weighted average common shares outstanding 39,847,860 37,727,868 39,013,412 37,604,594
FFO per common share $ 1.43 $ 1.80 $ 5.27 $ 5.31
Normalized FFO per common share $ 1.27 $ 1.17 $ 4.89 $ 4.67
Normalized AFFO per common share $ 1.15 $ 1.03 $ 4.41 $ 4.11
 

DILUTED

Weighted average common shares outstanding 39,993,445 37,741,162 39,155,380 37,644,171
FFO per common share $ 1.43 $ 1.80 $ 5.25 $ 5.31
Normalized FFO per common share $ 1.27 $ 1.17 $ 4.87 $ 4.67
Normalized AFFO per common share $ 1.15 $ 1.03 $ 4.39 $ 4.10
 

See Notes to Reconciliation of FFO, Normalized FFO, Normalized AFFO and Normalized FAD.

 

Notes to Reconciliation of FFO, Normalized FFO, Normalized AFFO and Normalized FAD

These supplemental operating performance measures may not be comparable to similarly titled measures used by other REITs. Consequently, our Funds From Operations ("FFO"), Normalized FFO, Normalized Adjusted Funds From Operations ("AFFO") and Normalized Funds Available for Distribution ("FAD") may not provide a meaningful measure of our performance as compared to that of other REITs. Since other REITs may not use our definition of these operating performance measures, caution should be exercised when comparing our Company's FFO, Normalized FFO, Normalized AFFO and Normalized FAD to that of other REITs. These financial performance measures do not represent cash generated from operating activities in accordance with generally accepted accounting principles ("GAAP") (these measures do not include changes in operating assets and liabilities) and therefore should not be considered an alternative to net earnings as an indication of operating performance, or to net cash flow from operating activities as determined by GAAP as a measure of liquidity, and are not necessarily indicative of cash available to fund cash needs.

Funds From Operations - FFO

FFO, as defined by the National Association of Real Estate Investment Trusts ("NAREIT") and applied by us, is net income (computed in accordance with GAAP), excluding gains (or losses) from sales of real estate property, plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures, if any. The Companys computation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or have a different interpretation of the current NAREIT definition from that of the Company; therefore, caution should be exercised when comparing our Companys FFO to that of other REITs. Diluted FFO assumes the exercise of stock options and other potentially dilutive securities. Normalized FFO excludes from FFO certain items which, due to their infrequent or unpredictable nature, may create some difficulty in comparing FFO for the current period to similar prior periods, and may include, but are not limited to, impairment of non-real estate assets, gains and losses attributable to the acquisition and disposition of assets and liabilities, and recoveries of previous write-downs.

We believe that FFO and normalized FFO are important supplemental measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative, and should be supplemented with a measure such as FFO. The term FFO was designed by the REIT industry to address this issue.

Adjusted Funds From Operations - AFFO

In addition to the adjustments included in the calculation of normalized FFO, normalized AFFO excludes the impact of any straight-line lease revenue, amortization of the original issue discount on our convertible senior notes and amortization of debt issuance costs.

We believe that normalized AFFO is an important supplemental measure of operating performance for a REIT. GAAP requires a lessor to recognize contractual lease payments into income on a straight-line basis over the expected term of the lease. This straight-line adjustment has the effect of reporting lease income that is significantly more or less than the contractual cash flows received pursuant to the terms of the lease agreement. GAAP also requires the original issue discount of our convertible senior notes and debt issuance costs to be amortized as non-cash adjustments to earnings. Normalized AFFO is useful to our investors as it reflects the growth inherent in the contractual lease payments of our real estate portfolio.

Funds Available for Distribution - FAD

In addition to the adjustments included in the calculation of normalized AFFO, normalized FAD excludes the impact of non-cash stock based compensation.

We believe that normalized FAD is an important supplemental measure of operating performance for a REIT as a useful indicator of the ability to distribute dividends to shareholders. Additionally, normalized FAD improves the understanding of our operating results among investors and makes comparisons with: (i) expected results, (ii) results of previous periods and (iii) results among REITs, more meaningful. Because FAD may function as a liquidity measure, we do not present FAD on a per-share basis.

       
Condensed Statements of Income
(in thousands, except share and per share amounts)
Three Months Ended Twelve Months Ended
December 31, December 31,
2016 2015 2016 2015
 
Revenues:
Rental income $ 61,019 $ 54,823 $ 232,393 $ 214,447
Interest income from mortgage and other notes 3,669 2,898 13,805 10,206
Investment income and other 339   982   2,302   4,335  
65,027   58,703   248,500   228,988  
Expenses:
Depreciation 15,897 13,660 59,565 53,163
Interest, including amortization of debt discount and issuance costs 11,364 10,158 43,108 37,629
Legal 16 169 422 464
Franchise, excise and other taxes 183 327 1,009 985
General and administrative 2,554 2,469 9,773 10,519
Loan and realty losses (recoveries) ?   ?   15,856   (491 )
30,014   26,783   129,733   102,269  

Income before equity-method investee, TRS tax benefit, investment and other gains and noncontrolling interest

35,013 31,920 118,767 126,719
Loss from equity-method investee ? (1,002 ) (1,214 ) (1,767 )
Income tax (expense) benefit attributable to taxable REIT subsidiary ? 401 (749 ) 707
Investment and other gains 6,175   23,468   35,912   24,655  
Net income 41,188 54,787 152,716 150,314
Less: net income attributable to noncontrolling interest ?   (390 ) (1,176 ) (1,452 )
Net income attributable to common stockholders $ 41,188   $ 54,397   $ 151,540   $ 148,862  
 
Weighted average common shares outstanding:
Basic 39,847,860 37,727,868 39,013,412 37,604,594
Diluted 39,993,445 37,741,162 39,155,380 37,644,171
 
Earnings per common share:
Net income attributable to common stockholders - basic $ 1.03 $ 1.44 $ 3.88 $ 3.96
Net income attributable to common stockholders - diluted $ 1.03 $ 1.44 $ 3.87 $ 3.95
 
Regular dividends declared per common share $ .90 $ .85 $ 3.60 $ 3.40
 
   
Selected Balance Sheet Data
(in thousands)
December 31, 2016 December 31, 2015
 
Real estate properties, net $ 2,159,774 $ 1,836,807
Mortgage and other notes receivable, net $ 133,493 $ 133,714
Cash and cash equivalents $ 4,832 $ 13,286
Marketable securities $ 11,745 $ 72,744
Straight-line rent receivable $ 72,518 $ 59,777
Equity-method investment and other assets $ 21,271 $ 15,544
Assets held for sale, net of depreciation $ ? $ 1,346
Debt $ 1,115,981 $ 914,443
National Health Investors Stockholders' equity $ 1,209,590 $ 1,133,292
 

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's, tenants', operators', borrowers or managers' expected future financial position, results of operations, cash flows, funds from operations, dividend and dividend plans, financing opportunities and plans, capital market transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, acquisition integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust (?REIT), plans and objectives of management for future operations, continued performance improvements, ability to service and refinance our debt obligations, ability to finance growth opportunities, and similar statements including, without limitation, those containing words such as ?may, ?will, ?believes, ?anticipates, ?expects, ?intends, ?estimates, ?plans, and other similar expressions are forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Such risks and uncertainties include, among other things; the operating success of our tenants and borrowers for collection of our lease and interest income; the success of property development and construction activities, which may fail to achieve the operating results we expect; the risk that our tenants and borrowers may become subject to bankruptcy or insolvency proceedings; risks related to governmental regulations and payors, principally Medicare and Medicaid, and the effect that lower reimbursement rates would have on our tenants and borrowers business; the risk that the cash flows of our tenants and borrowers would be adversely affected by increased liability claims and liability insurance costs; risks related to environmental laws and the costs associated with liabilities related to hazardous substances; the risk that we may not be fully indemnified by our lessees and borrowers against future litigation; the success of our future acquisitions and investments; our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms; the potential need to incur more debt in the future, which may not be available on terms acceptable to us; our ability to meet covenants related to our indebtedness which impose certain operational; the risk that the illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties; risks associated with our investments in unconsolidated entities, including our lack of sole decision-making authority and our reliance on the financial condition of other interests; our dependence on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt bears interest at variable rates; the risk that our assets may be subject to impairment charges; and our dependence on the ability to continue to qualify for taxation as a real estate investment trust. Many of these factors are beyond the control of the Company and its management. The Company assumes no obligation to update any of the foregoing or any other forward looking statements, except as required by law, and these statements speak only as of the date on which they are made. Investors are urged to carefully review and consider the various disclosures made by NHI in its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHIs Annual Report on Form 10-K for the most recently ended fiscal year. Copies of these filings are available at no cost on the SECs web site at http://www.sec.gov or on NHIs web site at http://www.nhireit.com.


Contacts

National Health Investors, Inc.
Roger R. Hopkins, Chief Accounting Officer, 615-890-9100


Page: 1


Related Keywords:

HOT THREADS on DMN Forums

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved